CRISPR assay development.
We help teams design, prototype, and refine CRISPR-based detection assays for specific molecular targets — from initial guide-RNA selection through to bench validation.
What we mean by CRISPR assay development.
CRISPR assay development is the engineering problem of turning a programmable molecular recognition system into a test that runs reliably on a real-world sample. The work spans three layers: the molecular logic of the assay (target sequence, recognition strategy), the biochemistry that produces a readable signal, and the workflow that turns that signal into something usable outside a research-grade laboratory.
Most engagements start at one of those three layers and expand outward. A team with a working chemistry that doesn’t survive a real sample matrix has a different problem than a team with a candidate target and no chemistry to detect it yet. We’ll help identify which problem you actually have before committing to how to solve it.
Our own work on RapidCan is an example of the same engineering problem, applied to cervical cancer screening. The discipline that work demanded is the discipline we bring to client engagements.
Who we work with.
Diagnostic developers
Companies building CRISPR-based products who need extra hands or external review on a specific layer of the assay.
Translational research groups
Academic teams moving from a published method toward a deployable assay that runs outside the originating lab.
Biotech R&D
Teams evaluating whether CRISPR is the right fit for a target before committing internal capacity to a programme.
How we work together.
Engagements begin with a target review and a written scope. From there, the work runs in milestones: chemistry decisions get committed, results get documented, and the path from each milestone to the next is agreed before the next one starts. If a result tells us the original plan won’t work, we say so and replan together — that’s the value of the engagement, not a failure of it.
Other ways we partner.
Molecular diagnostics consulting
Strategic guidance on assay architecture, sample workflows, and translation from concept to clinical use.
Clinical validation support
Study design, partner sourcing, and analytical-to-clinical performance evaluation for diagnostic candidates.
Regulatory strategy
IVDR-aligned planning for CE marking pathways, technical-file structuring, and post-market surveillance.
Contract research
Targeted laboratory work for biotech and pharmaceutical partners — flexible scope, rigorous documentation.
Global procurement services
Sourcing of medical devices, IVDs, and pharmaceuticals from European supply chains for international partners, with full audit and compliance documentation.
Talk to us about your target.
Tell us what you’re trying to detect and where the work is stuck. We’ll come back with how we’d approach it.